CoChat

Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases

Open access
Naftali Ben Haim, Liron, Moisseiev, Elad · 2021 · Pharmaceutics

The DOI matches its Crossref record; 110 of the 111 references it cites were found in a registry or an index.

Abstract

The suprachoroidal space (SCS), a potential space between the sclera and choroid, is becoming an applicable method to deliver therapeutics to the back of the eye. In recent years, a vast amount of research in the field has been carried out, with new discoveries in different areas of interest, such as imaging, drug delivery methods, pharmacokinetics, pharmacotherapies in preclinical and clinical trials and advanced therapies. The SCS can be visualized via advanced techniques of optical coherence tomography (OCT) in eyes with different pathologies, and even in healthy eyes. Drugs can be delivered easily and safely via hollow microneedles fitted to the length of the approximate thickness of the sclera. SCS injections were found to reach greater baseline concentrations in the target layers compared to intravitreal (IVT) injection, while agent clearance was faster with highly aqueous soluble molecules. Clinical trials with SCS injection of triamcinolone acetonide (TA) were executed with promising findings for patients with noninfectious uveitis (NIU), NIU implicated with macular edema and diabetic macular edema (DME). Gene therapy is evolving rapidly with viral and non-viral vectors that were found to be safe and efficient in preclinical trials. Here, we review these novel different aspects and new developments in clinical treatment of the posterior segment of the eye.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics13070967

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Different ocular drug administration routs; (1) topical route, (2) subconjunctival route, (3) suprachoroidal route with microcannula and microneedle, (4) subretinal route and (5) intravitreal injection. Reproduced from [5], CC BY 4.0 license, Published by MDPI 2021.
Figure 1 Different ocular drug administration routs; (1) topical route, (2) subconjunctival route, (3) suprachoroidal route with microcannula and microneedle, (4) subretinal route and (5) intravitreal injection. Reproduced from [5], CC BY 4.0 license, Published by MDPI 2021.CC BY · PubMed Central
Figure 2 Images demonstrating the SCS in OCT. The suprachoroidal space can be visualized as a hyporeflective band (white arrows), between the choroid and the sclera. (A) An image of the left eye of an 80-year-old female patient with age-related macular degeneration. (B) An image of the left eye of a 74-year-old male patient with age-related macular degeneration.
Figure 2 Images demonstrating the SCS in OCT. The suprachoroidal space can be visualized as a hyporeflective band (white arrows), between the choroid and the sclera. (A) An image of the left eye of an 80-year-old female patient with age-related macular degeneration. (B) An image of the left eye of a 74-year-old male patient with age-related macular degeneration.CC BY · PubMed Central
Figure 3 Hollow microneedle for SCS injection.
Figure 3 Hollow microneedle for SCS injection.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 110 references

Research works printed but not linked: 2

  1. Michalewska, 2013, Retinal Physician—Going Deeper and Wider, Retin. Physician, 10, 42
  2. Barakat, 2021, Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study, Ophthalmology, 5, 60

Cited by

See all 68

Metadata

Authors
Naftali Ben Haim, L., & Moisseiev, E.
Affiliations
  • Department of Ophthalmology, Meir Medical Center, Kfar Saba, 59 Tshernichovsky St., Kfar Saba 4428164, Israel
  • Tel Aviv University (IL)
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2021-06-26
Volume
13
Issue
7
Pages
967
ISSN
1999-4923 (ISSN-L)
OpenAlex
W3173820223
Cited by
68
References
111
Citations by year
2026: 10 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 11 · 2021: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
suprachoroidal space, drug delivery, retinal disease, sclera, choroid, hollow microneedles, intravitreal injection, triamcinolone acetonide, non-infectious uveitis, macular edema, diabetic macular edema, gene therapy, viral vectors, non-viral vectors, posterior segment of the eye, pharmacokinetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases. https://app.cochat.ai/papers/10.3390/pharmaceutics13070967
The paper
Naftali Ben Haim, L., & Moisseiev, E. (2021). Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13070967

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.